University of California/Tufts CTSI
Aug 8, 2025, 17:15
Patent Foramen Ovale and Stroke: David Kent and Andy Wang Break It Down
Vasculearn Network shared an insightful post on LinkedIn:
”ICYMI: PFO and Stroke – Who Benefits from Closure?
About 1 in 4 adults has a PFO, but not everyone needs it closed. A new July 2025 JAMA review reframes PFO closure as targeted, not routine, therapy for select stroke patients.
Key tools guiding treatment:
- RoPE score: Predicts if stroke is PFO-related
- PASCAL system: Adds anatomy to assess stroke causality
Best candidates?
- Age ≤60
- Cryptogenic stroke
- High PASCAL score
- No vascular risk factors
In these patients, closure cuts stroke recurrence risk by up to 90% at 2 years.
Everyone else? Medical therapy still leads with individualized decisions on antiplatelet vs. anticoagulant”
Find the full update on the community.
Read the full article here.
Article: Patent Foramen Ovale and Stroke. A Review
Authors: David M. Kent, Andy Y. Wang
Stay informed on all the scientific advances in hematology with Hemostasis Today.
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V J։ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem Khachatryan։ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity